0001517026-24-000002.txt : 20240415 0001517026-24-000002.hdr.sgml : 20240415 20240415162527 ACCESSION NUMBER: 0001517026-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240414 FILED AS OF DATE: 20240415 DATE AS OF CHANGE: 20240415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verratti Mark CENTRAL INDEX KEY: 0001517026 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 24844943 MAIL ADDRESS: STREET 1: 322 NORTH 2200 WEST CITY: SATL LAKE CITY STATE: UT ZIP: 84116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 322 NORTH 2200 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84116 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 322 NORTH 2200 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84116 4 1 wk-form4_1713212713.xml FORM 4 X0508 4 2024-04-14 0 0000899923 MYRIAD GENETICS INC MYGN 0001517026 Verratti Mark 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 0 1 0 0 Chief Commercial Officer 0 Common Stock 2024-04-14 4 F 0 1076 19.55 D 298715 D Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 12, 2024. By: Justin Hunter For: Mark Verratti 2024-04-15